The option that seemed to be missing was related to funding -- will the research using embryonic stem cells receive the same, less or more funding. And same question regarding stem cells taken from fetal tissue.
"Weaker" is a poor choice of words. Laissez faire and restraint is a sign of STRENGTH. The choices in the survey should be a spectrum between "Looser oversight --> Stricter oversight", even better... "Regulatory gridlock --> Doctor-Patient freedom"
I think the FDA will get this right.